Advertisement
Screener

Correvio Pharma Corp. Tangible Asset Impairment Charges

Correvio Pharma Corp. Tangible Asset Impairment Charges

Correvio Pharma Corp. reported Tangible Asset Impairment Charges of $0 for the 12-month period ending 2015-12-31, per its 40-F filed 2016-03-29.

Discontinued › Expense Statement › Operating Expenses

us-gaap:TangibleAssetImpairmentCharges · last filed 2016-03-29

Period endTangible Asset Impairment Charges 12 month
2015-12-31$0.00
40-F · filed 2016-03-29
2014-12-31$188.00K
40-F · filed 2016-03-29
2013-12-31$0.00
40-F · filed 2015-03-27